These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27248430)

  • 1. Quantitative Measurements of Enhancement on Preprocedure Triphasic CT Can Predict Response of Colorectal Liver Metastases to Radioembolization.
    Boas FE; Brody LA; Erinjeri JP; Yarmohammadi H; Shady W; Kishore S; Sofocleous CT
    AJR Am J Roentgenol; 2016 Sep; 207(3):671-5. PubMed ID: 27248430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.
    Shady W; Kishore S; Gavane S; Do RK; Osborne JR; Ulaner GA; Gonen M; Ziv E; Boas FE; Sofocleous CT
    Eur J Radiol; 2016 Jun; 85(6):1224-31. PubMed ID: 27161074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.
    Shady W; Sotirchos VS; Do RK; Pandit-Taskar N; Carrasquillo JA; Gonen M; Sofocleous CT
    AJR Am J Roentgenol; 2016 Sep; 207(3):661-70. PubMed ID: 27384594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal liver metastasis after 90Y radioembolization therapy: pilot study of change in MDCT attenuation as a surrogate marker for future FDG PET response.
    Tochetto SM; Töre HG; Chalian H; Yaghmai V
    AJR Am J Roentgenol; 2012 May; 198(5):1093-9. PubMed ID: 22528898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases.
    Morsbach F; Pfammatter T; Reiner CS; Fischer MA; Sah BR; Winklhofer S; Klotz E; Frauenfelder T; Knuth A; Seifert B; Schaefer N; Alkadhi H
    Invest Radiol; 2013 Nov; 48(11):787-94. PubMed ID: 23748229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
    Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Y90 radioembolization of colorectal cancer liver metastases: response assessment by contrast-enhanced computed tomography with or without PET-CT guidance.
    Vouche M; Salem R; Miller FH; Lemort M; Vanderlinden B; De Becker D; Hendlisz A; Flamen P
    Clin Imaging; 2015; 39(3):454-62. PubMed ID: 25724225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion.
    Reiner CS; Morsbach F; Sah BR; Puippe G; Schaefer N; Pfammatter T; Alkadhi H
    J Vasc Interv Radiol; 2014 May; 25(5):747-59. PubMed ID: 24630751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.
    Barabasch A; Kraemer NA; Ciritsis A; Hansen NL; Lierfeld M; Heinzel A; Trautwein C; Neumann U; Kuhl CK
    Invest Radiol; 2015 Jun; 50(6):409-15. PubMed ID: 25763526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-Response and Dose-Toxicity Relationships for Glass
    Alsultan AA; van Roekel C; Barentsz MW; Smits MLJ; Kunnen B; Koopman M; Braat AJAT; Bruijnen RCG; de Keizer B; Lam MGEH
    J Nucl Med; 2021 Nov; 62(11):1616-1623. PubMed ID: 33741643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases.
    Sato KT; Omary RA; Takehana C; Ibrahim S; Lewandowski RJ; Ryu RK; Salem R
    J Vasc Interv Radiol; 2009 Dec; 20(12):1564-9. PubMed ID: 19846320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres.
    Ulrich G; Dudeck O; Furth C; Ruf J; Grosser OS; Adolf D; Stiebler M; Ricke J; Amthauer H
    J Nucl Med; 2013 Apr; 54(4):516-22. PubMed ID: 23447653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Enhancement or Perfusion on Preprocedure CT Predict Outcomes After Embolization of Hepatocellular Carcinoma?
    Borgheresi A; Gonzalez-Aguirre A; Brown KT; Getrajdman GI; Erinjeri JP; Covey A; Yarmohammadi H; Ziv E; Sofocleous CT; Boas FE
    Acad Radiol; 2018 Dec; 25(12):1588-1594. PubMed ID: 29602726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases.
    van den Hoven AF; Rosenbaum CE; Elias SG; de Jong HW; Koopman M; Verkooijen HM; Alavi A; van den Bosch MA; Lam MG
    J Nucl Med; 2016 Jul; 57(7):1014-9. PubMed ID: 26912436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer.
    Fendler WP; Philippe Tiega DB; Ilhan H; Paprottka PM; Heinemann V; Jakobs TF; Bartenstein P; Hacker M; Haug AR
    J Nucl Med; 2013 Aug; 54(8):1202-8. PubMed ID: 23729697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver metastases on quantitative color mapping of the arterial enhancement fraction from multiphasic CT scans: evaluation of the hemodynamic features and correlation with the chemotherapy response.
    Joo I; Lee JM; Kim KW; Klotz E; Han JK; Choi BI
    Eur J Radiol; 2011 Dec; 80(3):e278-83. PubMed ID: 21251785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
    Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
    J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
    Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
    J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
    Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
    J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiographic response to yttrium-90 radioembolization in anterior versus posterior liver segments.
    Ibrahim SM; Lewandowski RJ; Ryu RK; Sato KT; Gates VL; Mulcahy MF; Kulik L; Larson AC; Omary RA; Salem R
    Cardiovasc Intervent Radiol; 2008; 31(6):1124-32. PubMed ID: 18509704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.